Company News for Jan 10, 2023

Zacks Equity Research Published on January 10, 2023

Shares of Regeneron Pharmaceuticals Inc. (REGN - Free Report) plummeted 7.7% after the company declared that sales of its Eylea drug were negatively impacted in fourth-quarter 2022 due to pressure from an off-label competitor.
Shares of Lululemon Athletica Inc. (LULU - Free Report) plunged 9.3% after the company reported that its gross margin has shrank in fourth-quarter 2022.
Duck Creek Technologies Inc. shares soared 46.5% after the company said that private equity firm Vista Equity Partners will acquire it for $19 per share.
Baxter International Inc. (BAX - Free Report) shares tumbled 7.7% after the company announced that it will spin off its kidney care business to restructure the company.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.